How Light Shapes Our Biology: The Science of Colour Therapy

1. The biological foundation: humans are light-regulated organisms

• About 1–2% of all human genes are under circadian control — meaning their expression changes depending on light exposure.
• Light not only enables vision but also regulates sleep, mood, energy metabolism, immune function, and hormones.
• These effects are mediated by non-visual photoreceptors in the eye, especially intrinsically photosensitive retinal ganglion cells (ipRGCs) that contain the pigment melanopsin.

When light enters the eye, it’s not just forming an image — it’s sending signals to the hypothalamus, particularly the suprachiasmatic nucleus (SCN), which acts as the brain’s master circadian clock.

2. Different colors — or wavelengths — trigger distinct hormonal and neurological responses:

Light therapy is now a clinical tool for seasonal depression, insomnia, and circadian rhythm disorders. Red and near-infrared light even stimulate mitochondrial repair and reduce inflammation (photobiomodulation).

In essence, color therapy works because light of different wavelengths interacts with specific photoreceptors, which then modulate hormones like melatonin, cortisol, serotonin, and dopamine — creating measurable effects on mood, sleep, and mental clarity

3. Neural and endocrine pathways

 Retina → Hypothalamus → Pineal gland

• • • Light → ipRGCs → SCN (circadian clock) → Pineal gland.
    • In darkness, the pineal gland converts serotonin into melatonin.
    • In light (especially blue), melatonin synthesis is suppressed, leading to wakefulness.

Hypothalamic–pituitary axis modulation

• • • Light intensity and spectrum affect the release of CRH (corticotropin-releasing hormone) and ACTH, influencing cortisol levels.
    • Morning blue light → ↑ cortisol → alertness, energy.
    • Evening exposure → cortisol remains high → insomnia and stress.

Serotonin and dopamine

• • • Bright light boosts tryptophan hydroxylase, the enzyme for serotonin synthesis.
    • Serotonin is a precursor for melatonin, so daytime exposure builds the chemical foundation for nighttime sleep.
    • Dopaminergic pathways in the retina and limbic system are also light-sensitive, influencing motivation and pleasure.

4. Psychological and perceptual dimensions

The perception of color itself — even aside from physiological effects — also modulates emotion and cognition via higher cortical networks:

These associations have been confirmed in EEG, fMRI, and hormonal studies — though context and cultural conditioning also influence responses.

5. Clinical applications of light therapy

Light therapy (“phototherapy”) has well-established medical uses:

• Seasonal affective disorder (SAD): 10,000 lux white or blue-enriched light each morning normalizes mood and sleep.
• Non-seasonal depression: Adjunctive light therapy improves serotonin and circadian rhythm.
• Sleep disorders: Red/amber light at night enhances melatonin secretion.
• Shift work or jet lag: Timed exposure to blue light helps re-entrain circadian cycles.
• Neurodegenerative diseases: Structured light exposure improves sleep-wake stability and cognitive alertness.

There’s also growing evidence for low-level red light therapy (photobiomodulation) at near-infrared wavelengths (~660–850 nm), which stimulates mitochondrial cytochrome c oxidase — increasing ATP production and reducing inflammation in neural tissue.

 6. The biochemical translation of light

Light affects hormonal and neurotransmitter systems at multiple levels:

Thus, the color and timing of light exposure shape the neuroendocrine landscape of the entire body.

 7. Summary

Light is both a physical signal (photon energy) and a biochemical regulator.

Different wavelengths — perceived as color — tune distinct aspects of our endocrine and emotional systems.

This is the core scientific basis behind color and light therapy: structured, wavelength-specific exposure that harmonizes the circadian, hormonal, and psychological systems.

8. Selected References

1. Münch, M. et al. “Attenuation of short wavelengths alters sleep and the ipRGC pupil response.” Ophthalmic & Physiological Optics, 37(3): 290-300 (2017).
   • Studied how blocking short-wavelength (blue) light at night increased melatonin levels and improved sleep duration. PubMed
   • Demonstrates how ipRGCs (melanopsin-containing) respond to short-wavelength light and influence circadian/hormonal systems.
2. Gooley, J. J. et al. “Light‐induced melatonin suppression in humans with polychromatic and monochromatic light.” Journal of Pineal Research, 46(1): 1-12 (2009).
   • Shows that blue (~479 nm) and polychromatic light both suppress melatonin, but additional wavelengths contribute beyond melanopsin alone. PubMed
   • Highlights that rods/cones in addition to ipRGCs play roles in non‐image forming (NIF) light responses.
3. Kawasaki, A. et al. “Association between melanopsin gene polymorphism (I394T) and pupillary light reflex is dependent on light wavelength.” Journal of Physiological Anthropology, 32: 16 (2013).
   • Found that people with different OPN4 (melanopsin) genotypes show different pupillary responses under blue vs green light (~465 nm vs ~532 nm). BioMed Central
   • Useful for linking photoreceptor genetics to spectral sensitivity and physiological output.
4. Spitschan, M. “Melanopsin contributions to non-visual and visual function.” Current Opinion in Behavioural Sciences, 30: 67-72 (2019).
   • A review summarizing how ipRGCs integrate input from rods/cones and melanopsin to drive circadian, pupillary, and mood/alertness responses. (Cited in consensus statement) Light for Public Health+1
5. Soucy, E. et al. “Rod Photoreceptor Activation Alone Defines the Release of Dopamine in the Retina.” Current Biology, 30(4): 510-516.e4 (2020).
   • Demonstrates that in the retina, dopamine release (a neuromodulator) is largely driven by rod photoreceptor activation under bright light, rather than ipRGC or cone input. PubMed
   • Links specific photoreceptors (rods) to neurotransmitter/hormonal responses in retina.
6. Hattar, S. et al. “The spectral sensitivity of human circadian phase resetting and melatonin suppression to light changes dynamically with light duration.” Journal of Pineal Research, 72(2): e12707 (2022).
   • Explores how the action spectrum for melatonin suppression in humans peaks around ~480 nm, but duration and irradiance matter. PubMed
7. Lucas, R. J., Peirson, S. N., Berson, D. M. et al. “Measuring and using light in the melanopsin age.” Trends in Neuroscience, 37(1): 1-9 (2014).

Foundational consensus review on non‐visual effects of light via ipRGCs and guidelines for research/lighting design. (Referenced in consensus website.) Light for Public Health